Sho Ohta
Tokyo, 1130033, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MYCN reprograms postnatal cells toward embryonic-like transcriptional states and drives tumorigenesis.
Journal: Biochemical and biophysical research communications
Published: July 22, 2026
Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development.
Journal: Nature communications
Published: January 19, 2026
A versatile in vivo platform for reversible control of transgene expression in adult tissues.
Journal: Stem cell reports
Published: July 02, 2024
Exploring the potential of in vivo reprogramming for studying embryonic development, tissue regeneration, and organismal aging.
Journal: Current opinion in genetics & development
Published: January 13, 2023
Generation of mice for evaluating endogenous p16Ink4a protein expression.
Journal: Biochemical and biophysical research communications
Published: January 11, 2022
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets.
Journal: Cell reports
Published: April 06, 2021
MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Journal: Nature metabolism
Published: February 10, 2021
DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency.
Journal: Nature communications
Published: November 04, 2020
RNA-binding protein Ptbp1 regulates alternative splicing and transcriptome in spermatogonia and maintains spermatogenesis in concert with Nanos3.
Journal: The Journal of reproduction and development
Published: July 07, 2020
Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells.
Journal: Biochemical and biophysical research communications
Published: August 06, 2019
Identification of distinct loci for de novo DNA methylation by DNMT3A and DNMT3B during mammalian development.
Journal: Nature communications
Published: August 01, 2019
Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
Journal: Nature communications
Published: February 11, 2019
Last Updated: 09/26/2026